Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Comment by Redbaron2211on Jan 28, 2021 7:54pm
283 Views
Post# 32416362

RE:Just Wondering II

RE:Just Wondering IIAgree DF more details would be appreciated but my take is this NR isn't for investors.  Feels like it's more tactical, not to be patronizing but I think about it like buying a home.  If it's a slow market and you know you're the only one looking, you are going to sit back and think about it.  If the realtor tells you there is alot of interest and potential offers you're not going to waste time.   In reality we might be able to get more value at later stages in the trial but if there are multiple interested parties it will be forward looking and once a tipping point is reached where greed outweighs risk you could easily see a buyout or licensing deal for valuations that would be more appropriate for the later stages.  Looking at preclinical companies like semma. That was a very forward looking acquisition.  Feels like anything is possible at this stage in the game.  Heading into a cell therapy revolution there is likely to be some aggressive acquisitions.  
<< Previous
Bullboard Posts
Next >>